XSHE
300396
Market cap287mUSD
Oct 09, Last price
7.29CNY
1D
3.40%
1Q
12.33%
Jan 2017
-65.31%
IPO
-29.89%
Name
Dirui Industrial Co Ltd
Chart & performance
P/E
—
P/S
2.46
EPS
—
Div yield, %
3.69%
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
-2.28%
Revenues
807m
-33.73%
Net income
0
-100.00%
CFO
39m
P
Dividend
May 20, 20250.26 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1992, Dirui Industrial Co.,Ltd. focuses on the research, production, and marketing of diagnostic medical solutions, primarily within the People's Republic of China. The company's product portfolio encompasses a variety of medical apparatus, diagnostic reagents, and testing strips. They provide advanced analyzers for diverse applications, including biochemical blood cell analysis, urinalysis, coagulation studies, chemiluminescence immunoassay, and gynecological secretion examinations. Its corporate headquarters are located in Changchun, China.
Key people
Qing Song
Chairman of the Board · since 2020
Xingyan Zhang
Chief Financial Officer, Deputy General Manager · since 2023
Xuemin Wang
General Manager, Director · since 2021
Deputy General Manager, Secretary of the Board, Director · since 2023
Dandan Niu
Deputy General Manager · since 2019
Bo Wang
Deputy General Manager · since 2019
Deputy General Manager · since 2022
Guoming Zheng
Deputy General Manager · since 2023
Director · since 2023
Bing Ni
Director · since 2023
Feng Qin
Director · since 2020
Mingyou An
Independent Director · since 2020
Qinggong Wu
Independent Director · since 2020
Independent Director · since 2020
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑00 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||